Stem cell-derived therapies
- Submission status
- Open
- Submission deadline
This Collection supports and amplifies research related to SDG 3 - Good health and wellbeing
All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number of endogenously occurring stem cells reduces, diminishing the capacity for the body to replace missing or dysfunctional cell types. Stem cell therapies aim to use stem cells, or products and cells derived from them, to repair tissues that are not functioning correctly because of damage, disease or abnormal development.
This Collection welcomes submissions that explore the therapeutic potential of stem cells or describe the use of stem cells and stem cell-derived products to treat human disease. We welcome submission of studies providing basic molecular and cellular insights into stem cell biology, preclinical and clinical studies, and studies that improve the production of human stem cell therapies.
This is a joint Collection across Nature Medicine, Nature Communications, Communications Medicine, Communications Biology and Scientific Reports. We encourage authors to choose which journal to submit to according to their own preference. However, before deciding which journal to submit to, the relevant journal webpages should be checked to ensure the submission is within scope for the journal. Each journal will apply its standard editorial criteria for scope and advance. Where submissions are more suitable for another participating journal, editors will recommend submission to a more appropriate alternative journal. Note that Nature Communications and Scientific Reports will only consider original research Articles.
